Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme

<div>The prognosis analysis of differentially expressed genes in GBM in TCGA cohort. (a) Overall survival analysis of CHI3L2 in GBM. (b) Progression-free survival analysis of CHI3L2 in GBM. (c) Disease-specific survival analysis of CHI3L2 in GBM.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme 